• Profile
Close

Meta-analysis comparing dual antiplatelet therapy vs single antiplatelet therapy following transcatheter aortic valve implantation

American Journal of Cardiology Jul 25, 2018

Siddamsetti S, et al. - Researchers analyzed data from all the trials comparing dual antiplatelet therapy (DAPT) to single antiplatelet therapy (SAPT) in patients undergoing transcathter aortic valve implantation (TAVI) via a meta-analysis including three randomized trials and four non-randomized studies. The rate of ischemic stroke was the primary endpoint, and the rates of myocardial infarction (MI), life threatening bleeding (LTB), significant bleeding (LTB and major bleeding), and death being the secondary end points. They used Mantel-Haenszel random effects model to calculate the combined odds ratios (OR) and 95% confidence intervals (CI) for outcomes at 30 days and up to 6-12 months follow-up. Based on the findings, they concluded no additional benefit of DAPT over SAPT following TAVI, as no difference in mortality, ischemic stroke and MI at 30 days or 6-12 month follow up was seen.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay